Masoprocol

Masoprocol
Systematic (IUPAC) name
4-[(2R,3S)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol
Clinical data
Trade names Actinex
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Topical
Pharmacokinetic data
Bioavailability Very low
Identifiers
CAS Number 500-38-9 YesY
ATC code L01XX10 (WHO)
PubChem CID 71398
IUPHAR/BPS 4265
DrugBank DB00179 YesY
ChemSpider 64490 YesY
UNII 7BO8G1BYQU YesY
ChEBI CHEBI:73468 N
ChEMBL CHEMBL313972 N
Chemical data
Formula C18H22O4
Molar mass 302.365 g/mol
 NYesY (what is this?)  (verify)

Masoprocol is an antineoplastic drug used to treat skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by mouth is being studied in the treatment of prostate cancer.

Also called nordihydroguaiaretic acid, NDGA, and actinex.

Mechanism

Nordihydroguaiaretic acid is an antioxidant, and it may block certain enzymes needed for tumor growth.

It is a lipoxygenase inhibitor.[1]

References

  1. "Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL". Am. J. Physiol. Endocrinol. Metab. 279 (3): E593–600. September 2000. PMID 10950827.

External links



This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.